Table S1.
Medication, physical therapy, and arthroplasty rates among female patients with hip and/or knee OA (total) in different age groups in % (95% CIs)
| Age group (years) | Total | |||||
|---|---|---|---|---|---|---|
| 60–69, n=110,352 | 70–79, n=184,124 | 80–89, n=99,199 | 90–99, n=21,902 | ≥100, n=486 | Total, n=416,063 | |
| Analgesics | ||||||
| Step 1 | 60.7 (60.4–61.0) | 62.2 (62.0–62.4) | 63.0 (62.7–63.3) | 62.3 (61.6–62.9) | 59.1 (54.5–63.5) | 62.0 (61.9–62.1) |
| Step 2 | 10.9 (10.7–11.1) | 14.3 (14.1–14.4) | 17.6 (17.3–17.8) | 18.0 (17.5–18.5) | 13.6 (10.7–17.0) | 14.4 (14.2–14.5) |
| Step 3 | 4.3 (4.1–4.4) | 6.2 (6.1–6.3) | 10.8 (10.6–11.0) | 15.7 (15.2–16.1) | 15.2 (12.1–18.7) | 7.3 (7.2–7.4) |
| NSAIDs | 49.1 (48.8–49.4) | 47.1 (46.8–47.3) | 40.1 (39.8–40.5) | 30.2 (29.6–30.8) | 19.3 (15.9–23.1) | 45.0 (44.9–45.2) |
| Coxib | 7.8 (7.7–8.0) | 7.3 (7.2–7.5) | 5.7 (5.6–5.8) | 4.0 (3.8–4.3) | 2.5 (1.3–4.3) | 6.9 (6.8–7.0) |
| Metamizol | 22.3 (22.1–22.6) | 28.3 (28.1–28.5) | 38.2 (37.9–38.5) | 46.1 (45.4–46.8) | 46.9 (42.4–51.5) | 30.0 (29.9–30.2) |
| Analgesics all | 63.2 (62.9–63.5) | 65.5 (65.2–65.7) | 68.1 (67.8–68.3) | 68.6 (68.0–69.2) | 66.0 (61.6–70.3) | 65.6 (65.5–65.8) |
| Physical therapy | ||||||
| Physiotherapy alla | 46.0 (45.7–46.3) | 48.2 (47.9–48.4) | 42.2 (41.9–42.5) | 33.6 (32.9–34.2) | 23.9 (20.1–27.9) | 45.4 (45.2–45.5) |
| Arthroplasty | ||||||
| THR | 2.9 (2.8–3.0) | 3.4 (3.3–3.4) | 2.6 (2.5–2.7) | 1.4 (1.3–1.6) | 1.2 (0.5–2.7) | 2.9 (2.9–3.0) |
| TKR | 2.9 (2.8–3.0) | 2.9 (2.9–3.0) | 1.7 (1.6–1.8) | 0.3 (0.2–0.5) | 0 (0.0–5.1) | 2.5 (2.4–2.5) |
| Total (THR or TKR) | 5.8 (5.6–5.9) | 6.2 (6.1–6.4) | 4.2 (4.1–4.4) | 1.7 (1.5–1.9) | 1.2 (0.5–2.7) | 5.4 (5.3–5.5) |
Note:
a
Physiotherapy, massage, physical therapy, exercise therapy, or electrotherapy.
Abbreviations: OA, osteoarthritis; NSAIDs, nonsteroidal anti-inflammatory drugs; THR, total hip replacement; TKR, total knee replacement.